positionForPages[95]={page:95,positions:[{w:"Research Publications",p:[0.674285,0.063855,0.896201,0.063855,0.896201,0.040840,0.674285,0.040840,0.016980,0.010442,0.009149,0.010442,0.011759,0.010014,0.010442,0.013076,0.005456,0.014370,0.013076,0.013076,0.006538,0.006538,0.010442,0.011759,0.007832,0.006538,0.011759,0.013076,0.009149]},{w:"The Clinical Outcomes Of Dapagliflozin In Patients With Acute Heart ",p:[0.104762,0.110014,0.902953,0.110014,0.902953,0.083711,0.104762,0.083711,0.017928,0.014944,0.011934,0.005591,0.019406,0.007472,0.007472,0.014944,0.007472,0.011934,0.013439,0.007472,0.005591,0.020911,0.014944,0.008950,0.011934,0.013439,0.022390,0.011934,0.010456,0.005591,0.020911,0.008950,0.005591,0.019406,0.013439,0.014944,0.013439,0.013439,0.007472,0.007472,0.008950,0.007472,0.013439,0.011934,0.007472,0.014944,0.005591,0.010456,0.014944,0.005591,0.016423,0.013439,0.008950,0.007472,0.011934,0.014944,0.008950,0.010456,0.005101,0.026392,0.007472,0.008950,0.014944,0.004107,0.019406,0.011934,0.014944,0.008950,0.011934,0.005591,0.020911,0.011934,0.013439,0.011934,0.008950,0.006720]},{w:"Failure: A Randomized Controlled Trial (Dapa-Response-Ahf)",p:[0.104762,0.136146,0.809720,0.136146,0.809720,0.109843,0.104762,0.109843,0.016423,0.013439,0.007472,0.007472,0.014944,0.011434,0.011934,0.008950,0.003422,0.017928,0.004919,0.019406,0.013439,0.014944,0.014944,0.013439,0.022390,0.007472,0.011934,0.011934,0.014944,0.004919,0.019406,0.013439,0.014944,0.008950,0.011453,0.013439,0.007472,0.007472,0.011934,0.014944,0.004413,0.015931,0.011934,0.007472,0.013439,0.007472,0.004895,0.008950,0.019406,0.013439,0.014944,0.013439,0.008950,0.019406,0.011934,0.010456,0.014944,0.013439,0.014944,0.010456,0.011934,0.008950,0.019406,0.014944,0.008950,0.008950]},{w:"European Journal Of Pharmacology. 2023 Dec; 961: 176179.",p:[0.201379,0.161149,0.799576,0.161149,0.799576,0.138882,0.201379,0.138882,0.015687,0.013076,0.009149,0.011759,0.011759,0.010442,0.011759,0.013076,0.005880,0.011759,0.011759,0.013076,0.009149,0.013076,0.011759,0.006538,0.005880,0.016980,0.007832,0.005880,0.014370,0.013076,0.011759,0.009149,0.018297,0.011759,0.010442,0.011759,0.006538,0.011759,0.011759,0.009577,0.005880,0.005880,0.011759,0.011759,0.011759,0.011759,0.005880,0.016980,0.010442,0.010442,0.007832,0.005880,0.011759,0.011759,0.011759,0.007832,0.005880,0.011759,0.011759,0.011759,0.011759,0.011759,0.011759,0.005880]},{w:"------------------------------------------------------------------------------------",p:[0.171534,0.187273,0.829393,0.187273,0.829393,0.164874,0.171534,0.164874,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832,0.007832]},{w:"Abdelrahman N Emara  , Moheb Wadie  , Noha O Mansour  , Mohamed E E Shams   ",p:[0.109612,0.213048,0.896799,0.213048,0.896799,0.192371,0.109612,0.192371,0.014566,0.010919,0.010919,0.009696,0.006071,0.008495,0.010919,0.012142,0.016990,0.010919,0.012142,0.005460,0.015767,0.005460,0.014566,0.016990,0.010919,0.008495,0.010919,0.005460,0.006369,0.005460,0.005460,0.019415,0.010919,0.012142,0.009696,0.010919,0.005067,0.017798,0.010919,0.010919,0.006071,0.009696,0.005460,0.006360,0.005460,0.005460,0.015767,0.010919,0.012142,0.010919,0.005460,0.015767,0.005460,0.019415,0.010919,0.012142,0.008495,0.010919,0.012142,0.008495,0.005460,0.015943,0.005460,0.005460,0.019415,0.010919,0.012142,0.010919,0.016990,0.009696,0.010919,0.005460,0.014566,0.005460,0.014566,0.005460,0.012142,0.012142,0.010919,0.016990,0.008495,0.005460,0.006372,0.005460]},{w:"1",p:[0.327433,0.205929,0.333799,0.205929,0.333799,0.193875,0.327433,0.193875,0.006366]},{w:"2",p:[0.473735,0.205929,0.480101,0.205929,0.480101,0.193875,0.473735,0.193875,0.006366]},{w:"1,3",p:[0.655471,0.205929,0.671386,0.205929,0.671386,0.193875,0.655471,0.193875,0.006366,0.003183,0.006366]},{w:"1",p:[0.884973,0.205929,0.891339,0.205929,0.891339,0.193875,0.884973,0.193875,0.006366]},{w:"Abstract",p:[0.104762,0.351949,0.213026,0.351949,0.213026,0.324002,0.104762,0.324002,0.020905,0.016164,0.011395,0.009795,0.012965,0.014565,0.012965,0.009510]},{w:"Aims:",p:[0.104762,0.373839,0.157074,0.373839,0.157074,0.354112,0.104762,0.354112,0.014756,0.005806,0.016994,0.008043,0.006713]},{w:" Dapagliflozin may confer additional decongestive and natriuretic benefits to patients with ",p:[0.157275,0.373540,0.900426,0.373540,0.900426,0.354340,0.157275,0.354340,0.004475,0.014756,0.009152,0.010281,0.009152,0.010281,0.005806,0.005806,0.006914,0.005806,0.010281,0.009152,0.005806,0.010281,0.004475,0.015885,0.009152,0.010281,0.004475,0.009152,0.010281,0.010281,0.006914,0.009152,0.006914,0.004475,0.009152,0.010281,0.010281,0.005806,0.005806,0.005806,0.010281,0.010281,0.009152,0.005806,0.004475,0.010281,0.009152,0.009152,0.010281,0.010281,0.010281,0.009152,0.008043,0.005806,0.005806,0.010281,0.009152,0.004475,0.009152,0.010281,0.010281,0.004475,0.010281,0.009152,0.005806,0.006914,0.005806,0.010281,0.006914,0.009152,0.005806,0.005806,0.009152,0.004475,0.010281,0.009152,0.010281,0.009152,0.006914,0.005806,0.005806,0.008043,0.004475,0.005806,0.010281,0.004475,0.010281,0.009152,0.005806,0.005806,0.009152,0.010281,0.005806,0.008043,0.004475,0.014756,0.005806,0.005806,0.010079,0.005040]},{w:"acute heart failure (AHF). Nonetheless, this hypothesis was not clinically examined. This study ",p:[0.104762,0.390644,0.900271,0.390644,0.900271,0.371444,0.104762,0.371444,0.009152,0.009152,0.010281,0.005806,0.009152,0.005503,0.010281,0.009152,0.009152,0.006914,0.005806,0.005503,0.006914,0.009152,0.005806,0.005806,0.010281,0.006914,0.009152,0.005503,0.006914,0.014756,0.014756,0.011410,0.006914,0.005241,0.005503,0.014756,0.010281,0.010281,0.009152,0.005806,0.010281,0.009152,0.005806,0.009152,0.008043,0.008043,0.005241,0.005503,0.005806,0.010281,0.005806,0.008043,0.005503,0.010281,0.010281,0.010281,0.010281,0.005806,0.010281,0.009152,0.008043,0.005806,0.008043,0.005503,0.014756,0.009152,0.008043,0.005503,0.010281,0.010281,0.005806,0.005503,0.009152,0.005806,0.005806,0.010281,0.005806,0.009152,0.009152,0.005806,0.005806,0.010281,0.005503,0.009152,0.010281,0.009152,0.015885,0.005806,0.010281,0.009152,0.010281,0.005241,0.005147,0.012519,0.010281,0.005806,0.008043,0.005503,0.008043,0.005806,0.010281,0.010281,0.010079,0.005040]},{w:"aimed primarily to investigate the effect of dapagliflozin on symptomatic relief in those patients.",p:[0.104762,0.407748,0.895407,0.407748,0.895407,0.388549,0.104762,0.388549,0.009152,0.005806,0.015885,0.009152,0.010281,0.004616,0.010281,0.006914,0.005806,0.015885,0.009152,0.006914,0.005806,0.005806,0.010281,0.004616,0.005806,0.010281,0.004616,0.005806,0.010281,0.010281,0.009152,0.008043,0.005806,0.005806,0.010281,0.009152,0.005806,0.009152,0.004616,0.005806,0.010281,0.009152,0.004616,0.009152,0.006552,0.006914,0.009152,0.009152,0.005806,0.004616,0.010281,0.006914,0.004616,0.010281,0.009152,0.010281,0.009152,0.010281,0.005806,0.005806,0.006914,0.005806,0.010281,0.009152,0.005806,0.010281,0.004616,0.010281,0.010281,0.004616,0.008043,0.010281,0.015885,0.010281,0.005806,0.010281,0.015885,0.009152,0.005806,0.005806,0.009152,0.004616,0.006914,0.009152,0.005806,0.005806,0.009152,0.006914,0.004616,0.005806,0.010281,0.004616,0.005806,0.010281,0.010281,0.008043,0.009152,0.004616,0.010281,0.009152,0.005806,0.005806,0.009152,0.010281,0.005806,0.008043,0.005040]},{w:"Methods:",p:[0.104762,0.431880,0.187917,0.431880,0.187917,0.412153,0.104762,0.412153,0.019231,0.009152,0.006914,0.011410,0.010281,0.011410,0.008043,0.006713]},{w:"  This was a randomized, double-blind study that included 87 patients with  AHF ",p:[0.188118,0.431580,0.900295,0.431580,0.900295,0.412381,0.188118,0.412381,0.005040,0.004096,0.012519,0.010281,0.005806,0.008043,0.009495,0.014756,0.009152,0.008043,0.009495,0.009152,0.009495,0.006914,0.009152,0.010281,0.010281,0.010281,0.015885,0.005806,0.009152,0.009152,0.010281,0.005241,0.009495,0.010281,0.010281,0.010281,0.010281,0.005806,0.009152,0.006914,0.010281,0.005806,0.005806,0.010281,0.010281,0.009495,0.008043,0.005806,0.010281,0.010281,0.010281,0.009495,0.005806,0.010281,0.009152,0.005806,0.009495,0.005806,0.010281,0.009152,0.005806,0.010281,0.010281,0.009152,0.010281,0.009495,0.010281,0.010281,0.009495,0.010281,0.009152,0.005806,0.005806,0.009152,0.010281,0.005806,0.008043,0.009495,0.014756,0.005806,0.005806,0.010281,0.005040,0.003348,0.014756,0.014756,0.011212,0.005040]},{w:"presenting with dyspnea. Within 24 h of admission, patients were randomized to receive either ",p:[0.104762,0.448685,0.900400,0.448685,0.900400,0.429485,0.104762,0.429485,0.010281,0.006914,0.009152,0.008043,0.009152,0.010281,0.005806,0.005806,0.010281,0.010281,0.006017,0.014756,0.005806,0.005806,0.010281,0.006017,0.010281,0.010281,0.008043,0.010281,0.010281,0.009152,0.009152,0.005241,0.005653,0.018421,0.005806,0.005806,0.010281,0.005806,0.010281,0.006027,0.010281,0.010281,0.006017,0.010281,0.006017,0.010281,0.006914,0.006017,0.009152,0.010281,0.015885,0.005806,0.008043,0.008043,0.005806,0.010281,0.010281,0.005241,0.006027,0.010281,0.009152,0.005806,0.005806,0.009152,0.010281,0.005806,0.008043,0.006027,0.014756,0.009152,0.006914,0.009152,0.006017,0.006914,0.009152,0.010281,0.010281,0.010281,0.015885,0.005806,0.009152,0.009152,0.010281,0.006017,0.005806,0.010281,0.006017,0.006914,0.009152,0.009152,0.009152,0.005806,0.010281,0.009152,0.006017,0.009152,0.005806,0.005806,0.010281,0.009152,0.006713,0.005040]},{w:"dapagliflozin (10 mg/day, N = 45) or placebo (N = 42) for 30 days. The primary outcome was the ",p:[0.104762,0.465789,0.900229,0.465789,0.900229,0.446590,0.104762,0.446590,0.010281,0.009152,0.010281,0.009152,0.010281,0.005806,0.005806,0.006914,0.005806,0.010281,0.009152,0.005806,0.010281,0.004455,0.006914,0.010281,0.010281,0.004455,0.015885,0.010281,0.005806,0.010281,0.009152,0.008973,0.005241,0.004455,0.014756,0.004455,0.011571,0.004455,0.010281,0.010281,0.006914,0.004455,0.010281,0.006914,0.004455,0.010281,0.005806,0.009152,0.009152,0.009152,0.010281,0.010281,0.004455,0.006914,0.014756,0.004455,0.011571,0.004455,0.010281,0.010281,0.006914,0.004455,0.006914,0.010281,0.006914,0.004455,0.010281,0.010281,0.004455,0.010281,0.009152,0.010281,0.008043,0.005241,0.004098,0.012519,0.010281,0.009152,0.004455,0.010281,0.006914,0.005806,0.015885,0.009152,0.006914,0.010281,0.004455,0.010281,0.010281,0.005806,0.009152,0.010281,0.015885,0.009152,0.004455,0.014756,0.009152,0.008043,0.004455,0.005806,0.010281,0.008946,0.005040]},{w:"difference between the two groups in the area under the curve (AUC) of visual analogue scale ",p:[0.104762,0.482894,0.900303,0.482894,0.900303,0.463694,0.104762,0.463694,0.010281,0.005806,0.006552,0.006914,0.009152,0.006914,0.009152,0.010281,0.009152,0.009152,0.006249,0.010281,0.009152,0.005806,0.014756,0.009152,0.009152,0.010281,0.006249,0.005806,0.010281,0.009152,0.006249,0.005806,0.014756,0.010281,0.006249,0.010281,0.006914,0.010281,0.010281,0.010281,0.008043,0.006249,0.005806,0.010281,0.006249,0.005806,0.010281,0.009152,0.006249,0.009152,0.006914,0.009152,0.009152,0.006249,0.010281,0.010281,0.010281,0.009152,0.006914,0.006249,0.005806,0.010281,0.009152,0.006249,0.009152,0.010281,0.006914,0.010281,0.009152,0.006249,0.006914,0.014756,0.014756,0.013647,0.006914,0.006249,0.010281,0.006914,0.006249,0.010281,0.005806,0.008043,0.010281,0.009152,0.005806,0.006249,0.009152,0.010281,0.009152,0.005806,0.010281,0.010281,0.010281,0.009152,0.006249,0.008043,0.009152,0.009152,0.005806,0.008948,0.005040]},{w:"(VAS) dyspnea score over the first 4 days. Secondary endpoints included urinary sodium (Na) ",p:[0.104762,0.499998,0.900311,0.499998,0.900311,0.480798,0.104762,0.480798,0.006914,0.012162,0.014756,0.011410,0.006914,0.006370,0.010281,0.010281,0.008043,0.010281,0.010281,0.009152,0.009152,0.006370,0.008043,0.009152,0.010281,0.006914,0.009152,0.006370,0.010281,0.010281,0.009152,0.006914,0.006370,0.005806,0.010281,0.009152,0.006370,0.006914,0.005806,0.006914,0.008043,0.005806,0.006370,0.010281,0.006370,0.010281,0.009152,0.010281,0.008043,0.005241,0.006370,0.011410,0.009152,0.009152,0.010281,0.010281,0.010281,0.009152,0.006914,0.010281,0.006370,0.009152,0.010281,0.010281,0.010281,0.010281,0.005806,0.010281,0.005806,0.008043,0.006370,0.005806,0.010281,0.009152,0.005806,0.010281,0.010281,0.009152,0.010281,0.006370,0.010281,0.006914,0.005806,0.010281,0.009152,0.006914,0.010281,0.006370,0.008043,0.010281,0.010281,0.005806,0.010281,0.015885,0.006370,0.006914,0.014756,0.009152,0.006713,0.005040]},{w:"after 2 h of randomization, percent change in NT-proBNP, cumulative urine output (UOP), and ",p:[0.104762,0.517102,0.900372,0.517102,0.900372,0.497903,0.104762,0.497903,0.009152,0.006914,0.005806,0.009152,0.006914,0.005886,0.010281,0.005886,0.010281,0.005886,0.010281,0.006914,0.005886,0.006914,0.009152,0.010281,0.010281,0.010281,0.015885,0.005806,0.009152,0.009152,0.005806,0.005806,0.010281,0.010281,0.005241,0.005886,0.010281,0.009152,0.006914,0.009152,0.009152,0.010281,0.005806,0.005886,0.009152,0.010281,0.009152,0.010281,0.010281,0.009152,0.005886,0.005806,0.010281,0.005886,0.014756,0.010664,0.006914,0.010281,0.006914,0.010281,0.013647,0.014756,0.009178,0.005241,0.005886,0.009152,0.010281,0.015885,0.010281,0.005806,0.009152,0.005806,0.005806,0.010281,0.009152,0.005886,0.010281,0.006914,0.005806,0.010281,0.009152,0.005886,0.010281,0.010281,0.005806,0.010281,0.010281,0.005806,0.005886,0.006914,0.014756,0.014756,0.011410,0.006914,0.005241,0.005886,0.009152,0.010281,0.010079,0.005040]},{w:"differences in mortality and hospital readmission rates.",p:[0.104762,0.534207,0.566941,0.534207,0.566941,0.515007,0.104762,0.515007,0.010281,0.005806,0.006552,0.006914,0.009152,0.006914,0.009152,0.010281,0.009152,0.009152,0.008043,0.006673,0.005806,0.010281,0.006673,0.015885,0.010281,0.006914,0.005806,0.009152,0.005806,0.005806,0.005806,0.010281,0.006673,0.009152,0.010281,0.010281,0.006673,0.010281,0.010281,0.008043,0.010281,0.005806,0.005806,0.009152,0.005806,0.006673,0.006914,0.009152,0.009152,0.010281,0.015885,0.005806,0.008043,0.008043,0.005806,0.010281,0.010281,0.006673,0.006914,0.009152,0.005806,0.009152,0.008043,0.005040]},{w:"Results:",p:[0.104762,0.558338,0.175600,0.558338,0.175600,0.538611,0.104762,0.538611,0.014756,0.009152,0.008043,0.011410,0.005806,0.006914,0.008043,0.006713]},{w:" The results showed that dapagliflozin significantly reduced the AUC of VAS dyspnea ",p:[0.175801,0.558039,0.900251,0.558039,0.900251,0.538839,0.175801,0.538839,0.005693,0.012519,0.010281,0.009152,0.006048,0.006914,0.009152,0.008043,0.010281,0.005806,0.005806,0.008043,0.006048,0.008043,0.010281,0.010281,0.014756,0.009152,0.010281,0.006048,0.005806,0.010281,0.009152,0.005806,0.006048,0.010281,0.009152,0.010281,0.009152,0.010281,0.005806,0.005806,0.006914,0.005806,0.010281,0.009152,0.005806,0.010281,0.006048,0.008043,0.005806,0.010281,0.010281,0.005806,0.006914,0.005806,0.009152,0.009152,0.010281,0.005806,0.005806,0.010281,0.006048,0.006914,0.009152,0.010281,0.010281,0.009152,0.009152,0.010281,0.006048,0.005806,0.010281,0.009152,0.004945,0.014756,0.014756,0.013647,0.006048,0.010281,0.006914,0.005693,0.012162,0.014756,0.011410,0.006048,0.010281,0.010281,0.008043,0.010281,0.010281,0.009152,0.008948,0.005040]},{w:"score compared to placebo (3192.2 ± 1631.9 mm × h vs 4713.1 ± 1714.9 mm × h, P < 0.001). ",p:[0.104762,0.575143,0.900386,0.575143,0.900386,0.555944,0.104762,0.555944,0.008043,0.009152,0.010281,0.006914,0.009152,0.006229,0.009152,0.010281,0.015885,0.010281,0.009152,0.006914,0.009152,0.010281,0.006229,0.005806,0.010281,0.006229,0.010281,0.005806,0.009152,0.009152,0.009152,0.010281,0.010281,0.006229,0.006914,0.010281,0.010281,0.010281,0.010281,0.005241,0.010281,0.006229,0.011269,0.006229,0.010281,0.010281,0.010281,0.010281,0.005241,0.010281,0.006229,0.015885,0.015885,0.006229,0.011571,0.006229,0.010281,0.006229,0.010281,0.008043,0.006229,0.010281,0.010281,0.010281,0.010281,0.005241,0.010281,0.006229,0.011269,0.006229,0.010281,0.010281,0.010281,0.010281,0.005241,0.010281,0.006229,0.015885,0.015885,0.006229,0.011571,0.006229,0.010281,0.005241,0.006229,0.010664,0.006229,0.011571,0.006229,0.010281,0.005241,0.010281,0.010281,0.010281,0.006914,0.005040,0.005040]},{w:"The relative change of NT-proBNP compared to its baseline was also larger with dapagliflozin ",p:[0.104762,0.592248,0.900386,0.592248,0.900386,0.573048,0.104762,0.573048,0.012519,0.010281,0.009152,0.006088,0.006914,0.009152,0.005806,0.009152,0.005806,0.005806,0.010281,0.009152,0.006088,0.009152,0.010281,0.009152,0.010281,0.010281,0.009152,0.006088,0.010281,0.006914,0.006088,0.014756,0.010666,0.006914,0.010281,0.006914,0.010281,0.013647,0.014756,0.010664,0.006088,0.009152,0.010281,0.015885,0.010281,0.009152,0.006914,0.009152,0.010281,0.006088,0.005806,0.010281,0.006088,0.005806,0.005806,0.008043,0.006088,0.010281,0.009152,0.008043,0.009152,0.005806,0.005806,0.010281,0.009152,0.006088,0.014756,0.009152,0.008043,0.006088,0.009152,0.005806,0.008043,0.010281,0.006088,0.005806,0.009152,0.006550,0.010281,0.009152,0.006914,0.006088,0.014756,0.005806,0.005806,0.010281,0.006088,0.010281,0.009152,0.010281,0.009152,0.010281,0.005806,0.005806,0.006914,0.005806,0.010281,0.009152,0.005806,0.010079,0.005040]},{w:"(-34.89% vs -10.085%, P = 0.001). Additionally, higher cumulative UOP was found at day 4 (18600 ",p:[0.104762,0.609352,0.900416,0.609352,0.900416,0.590152,0.104762,0.590152,0.006914,0.006914,0.010281,0.010281,0.005241,0.010281,0.010281,0.016994,0.002923,0.010281,0.008043,0.002923,0.006914,0.010281,0.010281,0.005241,0.010281,0.010281,0.010281,0.016994,0.005241,0.002923,0.010664,0.002923,0.011571,0.002923,0.010281,0.005241,0.010281,0.010281,0.010281,0.006914,0.005241,0.001804,0.014756,0.010281,0.010281,0.005806,0.005806,0.005806,0.010281,0.010281,0.009152,0.005806,0.005806,0.008971,0.005241,0.002923,0.010281,0.005806,0.010281,0.010281,0.009152,0.006914,0.002923,0.009152,0.010281,0.015885,0.010281,0.005806,0.009152,0.005806,0.005806,0.010281,0.009152,0.002923,0.014756,0.014756,0.010664,0.002923,0.014756,0.009152,0.008043,0.002923,0.006914,0.010281,0.010281,0.010281,0.010281,0.002923,0.009152,0.005806,0.002923,0.010281,0.009152,0.010281,0.002923,0.010281,0.002923,0.006914,0.010281,0.010281,0.010281,0.010281,0.010079,0.005040]},{w:"ml in dapagliflozin vs 13700 in placebo, P = 0.031). Dapagliflozin decreased rehospitalization ",p:[0.104762,0.626456,0.900328,0.626456,0.900328,0.607257,0.104762,0.607257,0.015885,0.005806,0.006290,0.005806,0.010281,0.006290,0.010281,0.009152,0.010281,0.009152,0.010281,0.005806,0.005806,0.006914,0.005806,0.010281,0.009152,0.005806,0.010281,0.006290,0.010281,0.008043,0.006290,0.010281,0.010281,0.010281,0.010281,0.010281,0.006290,0.005806,0.010281,0.006290,0.010281,0.005806,0.009152,0.009152,0.009152,0.010281,0.010281,0.005241,0.006290,0.010666,0.006290,0.011571,0.006290,0.010281,0.005241,0.010281,0.010281,0.010281,0.006914,0.005241,0.006290,0.014756,0.009152,0.010281,0.009152,0.010281,0.005806,0.005806,0.006914,0.005806,0.010281,0.009152,0.005806,0.010281,0.006290,0.010281,0.009152,0.009152,0.006914,0.009152,0.009152,0.008043,0.009152,0.010281,0.006290,0.006914,0.009152,0.010281,0.010281,0.008043,0.010281,0.005806,0.005806,0.009152,0.005806,0.005806,0.009152,0.009152,0.005806,0.005806,0.010281,0.010079,0.005040]},{w:"rates within 30 days after discharge, while it did not affect the spot urinary Na concentration, ",p:[0.104762,0.643561,0.900245,0.643561,0.900245,0.624361,0.104762,0.624361,0.006914,0.009152,0.005806,0.009152,0.008043,0.006733,0.014756,0.005806,0.005806,0.010281,0.005806,0.010281,0.006733,0.010281,0.010281,0.006733,0.010281,0.009152,0.010281,0.008043,0.006733,0.009152,0.006914,0.005806,0.009152,0.006914,0.006733,0.010281,0.005806,0.008043,0.009152,0.010281,0.009152,0.006550,0.010281,0.009152,0.005241,0.006733,0.014756,0.010281,0.005806,0.005806,0.009152,0.006733,0.005806,0.005806,0.006733,0.010281,0.005806,0.010281,0.006733,0.010281,0.010281,0.005806,0.006733,0.009152,0.006552,0.006914,0.009152,0.009152,0.005806,0.006733,0.005806,0.010281,0.009152,0.006733,0.008043,0.010281,0.010281,0.005806,0.006733,0.010281,0.006914,0.005806,0.010281,0.009152,0.006914,0.010281,0.006733,0.014756,0.009152,0.006733,0.009152,0.010281,0.010281,0.009152,0.009152,0.010281,0.005806,0.006914,0.009152,0.005806,0.005806,0.010281,0.010281,0.005042,0.005040]},{w:"incidence of worsening of heart failure, or mortality rates.",p:[0.104762,0.660665,0.587906,0.660665,0.587906,0.641465,0.104762,0.641465,0.005806,0.010281,0.009152,0.005806,0.010281,0.009152,0.010281,0.009152,0.009152,0.005786,0.010281,0.006914,0.005786,0.014756,0.010281,0.006914,0.008043,0.009152,0.010281,0.005806,0.010281,0.010281,0.005786,0.010281,0.006914,0.005786,0.010281,0.009152,0.009152,0.006914,0.005806,0.005786,0.006914,0.009152,0.005806,0.005806,0.010281,0.006914,0.009152,0.005241,0.005786,0.010281,0.006914,0.005786,0.015885,0.010281,0.006914,0.005806,0.009152,0.005806,0.005806,0.005806,0.010281,0.005786,0.006914,0.009152,0.005806,0.009152,0.008043,0.005040]},{w:"Conclusion:",p:[0.104762,0.684796,0.209829,0.684796,0.209829,0.665069,0.104762,0.665069,0.014756,0.010281,0.011410,0.009152,0.005806,0.011410,0.008043,0.005806,0.010281,0.011410,0.006713]},{w:" Dapagliflozin may provide symptomatic relief and improve diuresis in patients ",p:[0.210031,0.684497,0.900390,0.684497,0.900390,0.665297,0.210031,0.665297,0.008053,0.014756,0.009152,0.010281,0.009152,0.010281,0.005806,0.005806,0.006914,0.005806,0.010281,0.009152,0.005806,0.010281,0.008053,0.015885,0.009152,0.010281,0.008053,0.010281,0.006914,0.010281,0.010281,0.005806,0.010281,0.009152,0.008053,0.008043,0.010281,0.015885,0.010281,0.005806,0.010281,0.015885,0.009152,0.005806,0.005806,0.009152,0.008063,0.006914,0.009152,0.005806,0.005806,0.009152,0.006914,0.008053,0.009152,0.010281,0.010281,0.008063,0.005806,0.015885,0.010281,0.006914,0.010281,0.010281,0.009152,0.008053,0.010281,0.005806,0.010281,0.006914,0.009152,0.008043,0.005806,0.008043,0.008053,0.005806,0.010281,0.008053,0.010281,0.009152,0.005806,0.005806,0.009152,0.010281,0.005806,0.007846,0.005040]},{w:"with AHF. Further studies are needed to confirm these findings.",p:[0.104762,0.701602,0.649606,0.701602,0.649606,0.682402,0.104762,0.682402,0.014756,0.005806,0.005806,0.010281,0.006281,0.014756,0.014756,0.009799,0.005241,0.007398,0.011410,0.010281,0.006914,0.005806,0.010281,0.009152,0.006914,0.007398,0.008043,0.005806,0.010281,0.010281,0.005806,0.009152,0.008043,0.007398,0.009152,0.006914,0.009152,0.007398,0.010281,0.009152,0.009152,0.010281,0.009152,0.010281,0.007398,0.005806,0.010281,0.007398,0.009152,0.010281,0.010281,0.006914,0.005806,0.006914,0.015885,0.007398,0.005806,0.010281,0.009152,0.008043,0.009152,0.007398,0.006914,0.005806,0.010281,0.010281,0.005806,0.010281,0.010281,0.008043,0.005040]},{w:"1",p:[0.104762,0.232332,0.109659,0.232332,0.109659,0.223005,0.104762,0.223005,0.004897]},{w:" Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University, Mansoura, ",p:[0.109757,0.237808,0.899526,0.237808,0.899526,0.221809,0.109757,0.221809,0.006132,0.011373,0.004838,0.004838,0.008567,0.004838,0.007627,0.007627,0.004838,0.006132,0.009508,0.008567,0.007627,0.005762,0.013238,0.007627,0.007627,0.008567,0.006132,0.007627,0.008567,0.008567,0.006132,0.009508,0.008567,0.007627,0.005762,0.013238,0.007627,0.007627,0.008567,0.006132,0.009508,0.005762,0.007627,0.007627,0.004838,0.004838,0.007627,0.007627,0.006132,0.012297,0.007627,0.008567,0.007627,0.005762,0.004838,0.013238,0.007627,0.008567,0.004838,0.004368,0.006132,0.009508,0.007627,0.007627,0.008567,0.004838,0.004838,0.008567,0.006132,0.008567,0.005762,0.006132,0.009508,0.008567,0.007627,0.005762,0.013238,0.007627,0.007627,0.007476,0.004368,0.006132,0.015102,0.007627,0.008567,0.006703,0.008567,0.008567,0.005762,0.007627,0.006132,0.012297,0.008567,0.004838,0.008567,0.007627,0.005762,0.006703,0.004838,0.004838,0.007477,0.004368,0.006132,0.015102,0.007627,0.008567,0.006703,0.008567,0.008567,0.005762,0.007627,0.004200,0.004200]},{w:"35516, Egypt.",p:[0.119046,0.252062,0.218446,0.252062,0.218446,0.236062,0.119046,0.236062,0.008567,0.008567,0.008567,0.008567,0.008567,0.004368,0.007022,0.010432,0.008567,0.008567,0.008567,0.004838,0.004200]},{w:"2",p:[0.104762,0.267574,0.109659,0.267574,0.109659,0.258246,0.104762,0.258246,0.004897]},{w:" Cardiology Department, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.",p:[0.109757,0.273050,0.760799,0.273050,0.760799,0.257050,0.109757,0.257050,0.004368,0.011373,0.007627,0.005762,0.008567,0.004838,0.008567,0.004838,0.008567,0.008567,0.008567,0.004368,0.012297,0.007627,0.008567,0.007627,0.005762,0.004838,0.013238,0.007627,0.008567,0.004838,0.004368,0.004368,0.009508,0.007627,0.007627,0.008567,0.004838,0.004838,0.008567,0.004368,0.008567,0.005762,0.004368,0.015102,0.007627,0.008567,0.004838,0.007627,0.004838,0.008567,0.007627,0.004368,0.004368,0.015102,0.007627,0.008567,0.006703,0.008567,0.008567,0.005762,0.007627,0.004368,0.012297,0.008567,0.004838,0.008567,0.007627,0.005762,0.006703,0.004838,0.004838,0.007476,0.004368,0.004368,0.015102,0.007627,0.008567,0.006703,0.008567,0.008567,0.005762,0.007627,0.004368,0.004368,0.008567,0.008567,0.008567,0.008567,0.008567,0.004368,0.004368,0.010432,0.008567,0.008567,0.008567,0.004838,0.004200]},{w:"3",p:[0.104762,0.288561,0.109659,0.288561,0.109659,0.279234,0.104762,0.279234,0.004897]},{w:" Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, ",p:[0.109757,0.294037,0.672019,0.294037,0.672019,0.278038,0.109757,0.278038,0.007022,0.011373,0.004838,0.004838,0.008567,0.004838,0.007627,0.007627,0.004838,0.007022,0.009508,0.008567,0.007627,0.005762,0.013238,0.007627,0.007627,0.008567,0.007022,0.007627,0.008567,0.008567,0.007022,0.009508,0.008567,0.007627,0.005762,0.013238,0.007627,0.007627,0.008567,0.007022,0.009508,0.005762,0.007627,0.007627,0.004838,0.004838,0.007627,0.007627,0.007022,0.012297,0.007627,0.008567,0.007627,0.005762,0.004838,0.013238,0.007627,0.008567,0.004838,0.004368,0.007022,0.009508,0.007627,0.007627,0.008567,0.004838,0.004838,0.008567,0.007022,0.008567,0.005762,0.007022,0.009508,0.008567,0.007627,0.005762,0.013238,0.007627,0.007627,0.007477,0.004368,0.004200]},{w:"Mansoura National University",p:[0.674841,0.294037,0.890942,0.294037,0.890942,0.278240,0.674841,0.278240,0.014161,0.008567,0.008567,0.006703,0.008567,0.008567,0.006703,0.008567,0.007022,0.011373,0.008567,0.004838,0.004838,0.008567,0.008567,0.008567,0.004838,0.007022,0.012297,0.008567,0.004838,0.007627,0.007627,0.006703,0.006703,0.004838,0.004838,0.007459]},{w:",        ",p:[0.891110,0.294037,0.899510,0.294037,0.899510,0.278038,0.891110,0.278038,0.004200,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.000000,0.004200]},{w:"Egypt.",p:[0.119046,0.308291,0.166131,0.308291,0.166131,0.292291,0.119046,0.292291,0.010808,0.008954,0.008954,0.008954,0.005214,0.004200]},{w:"Vol. 2 - Issue 1",p:[0.743337,0.965677,0.857137,0.965677,0.857137,0.947594,0.743337,0.947594,0.011649,0.009239,0.005137,0.004620,0.004620,0.009239,0.004620,0.006153,0.004620,0.007188,0.007188,0.007188,0.010274,0.008205,0.004620,0.009239]},{w:"95",p:[0.864761,0.971012,0.897116,0.971012,0.897116,0.940075,0.864761,0.940075,0.015815,0.016540]},{w:"Reference:",p:[0.104762,0.735091,0.210548,0.735091,0.210548,0.712824,0.104762,0.712824,0.015687,0.010442,0.007832,0.010442,0.009149,0.010442,0.013076,0.010442,0.010442,0.007832]},{w:"https://doi.org/10.1016/j.ejphar.2023.176179",p:[0.104762,0.754620,0.405427,0.754620,0.405427,0.738620,0.104762,0.738620,0.008399,0.004670,0.004670,0.008399,0.006535,0.004670,0.004670,0.004670,0.008399,0.008399,0.004670,0.004200,0.008399,0.005277,0.008399,0.004670,0.008399,0.008399,0.004200,0.008399,0.008399,0.008399,0.008399,0.004670,0.004670,0.004200,0.007459,0.004670,0.008399,0.008399,0.007459,0.004650,0.004200,0.008399,0.008399,0.008399,0.008399,0.004200,0.008399,0.008399,0.008399,0.008399,0.008399,0.008399]}]};